Current Issue - March 2022, Volume 16, Issue No. 1

1. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018; 41(5): 917-928. doi: 10.2337/dci18-0007
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047-53. doi: 10.2337/diacare.27.5.1047
3. Institute for Public Health (IPH). The National Health and Morbidity Survey 2011 (NHMS 2011). Ministry of Health Malaysia; 2011.
4. Institute for Public Health (IPH). The National Health and Morbidity Survey 2015 (NHMS 2015) Vol II: Non-Communicable Disease, Risk Factors and Other Health Problems. Ministry of Health Malaysia. 2015.
5. Kow RY, Low CL, Ruben JK, Zaharul Azri WMZ, Mor Japar Khan ESK. Microbiology of diabetic foot infections in three district hospital in Malaysia and comparison with South East Asian Countries. Med J Malaysia. 2019; 74(5): 394-9.
6. Feisul MI, Azmi S. National Diabetic Registry Report, Volume 1, 2009-2012. Kuala Lumpur: Ministry of Health Malaysia; 2013.
7. Noor S, Zubair M, Ahmad J. Diabetic foot ulcer--A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr. 2015; 9(3): 192-9. doi: 10.1016/j.dsx.2015.04.007
8. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005; 293(2): 217-28. doi: 10.1001/jama.293.2.217
9. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005; 366(9498): 1719-24. doi: 10.1016/S0140-6736(05)67698-2
10. Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, et al. Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia. 2010; 65(3): 180-6.
11. Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ. Diabetes-related lower extremity complications are a leading cause of the global burden of disability. Diabet Med. 2018; 35(9): 1297-9. doi: 10.1111/dme.13680
12. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017; 376(24): 2367-75. doi: 10.1056/NEJMra1615439
13. The International Diabetes Federation (IDF) and the International Working Group on the Diabetic Foot (IWGDF). Diabetes and Foot Care: Time to Act. 2005. https://www.worlddiabetesfoundation.org/sites/default/files/Diabetes%20and%20Foot%20care_ Time%20to%20act.pdf (accessed on 20 March 2020)
14. Bus SA, van Netten JJ, Monteiro-Soares M, Lipsky BA, Schaper NC. Diabetic foot disease: "The Times They are A Changin' ". Diabetes Metab Res Rev. 2020; 36 Suppl 1(Suppl 1): e3249. doi: 10.1002/dmrr.3249
15. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012; 54(12): e132-73. doi: 10.1093/cid/cis346
16. Zenelaj B, Bouvet C, Lipsky BA, Uckay I. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens? Int J Low Extrem Wounds. 2014; 13(4): 263-72. doi: 10.1177/1534734614550311
17. Kow RY, Low CL, Ruben JK, Zaharul-Azri MZ, Lim BC. Predictive Factors of Major Lower Extremity Amputations in Diabetic Foot Infections: A Cross-sectional Study at District Hospital in Malaysia. Malays Orthop J. 2019; 13(3): 45-52. doi: 10.5704/MOJ.1911.008
18. Raja NS. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J Microbiol Immunol Infect. 2007; 40(1): 39-44.
19. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI document M100. Wayne PA: Clinical Laboratory Standard Institute; 2019.
20. Yusof NM, Rahman JA, Zulkifly AH, Che-Ahmad A, Khalid KA, Sulong AF, et al. Predictors of major lower limb amputation among type II diabetic patients admitted for diabetic foot problems. Singapore Med J. 2015; 56(11): 626-31. doi: 10.11622/smedj.2015172
21. Nather A, Bee CS, Huak CY, Chew JL, Lin CB, Neo S, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications. 2008; 22(2): 77-82. doi: 10.1016/j.jdiacomp.2007.04.004
22. Leung HB, Ho YC, Carnett J, Lam PK, Wong WC. Diabetic foot ulcers in the Hong Kong Chinese population: retrospective study. Hong Kong Med J. 2001; 7(4): 350-5.
23. Harwant S, Doshi HK, Moissinac K, Abdullah BT. Factors related to adverse outcome in inpatients with diabetic foot. Med J Malaysia. 2000; 55(2): 236-41.
24. Wan Hazmy CH, Chia WY, Fong TS, Ganendra P. Functional outcome after major lower limb extremity amputation: a survey on lower extremity amputees. Med J Malaysia. 2006; 61 Suppl A: 3-9.
25. Marik PE. Don’t miss the diagnosis of sepsis! Crit Care. 2014; 18(5): 529. doi: 10.1186/s13054-014-0529-6
26. Son TS, Han SK, Lee TY, Namgoong S, Dhong ES. The Microbiology of Diabetic Foot Infections in Korea. J Wound Management Res. 2017; 13(1): 8-12. doi: 10.22467/jwmr.2017.00108
27. Ministry of Health Malaysia. National Antimicrobial Guideline (NAG) 2019. Petaling Jaya: Pharmaceutical Services Programme Ministry of Health Malaysia; 2019.

Abstract   |   Reference